An interventional randomized trial to demonstrate the equivalence in the safety and efficacy profile between MYL-1601D and ovoLog® in volunteers with T1DM.
Mylan insulin Aspart trial in Volunteers with Type 1 Diabetes Basal/ Bolus Insulin Users
The Gazelle Study
Study Length: 7 months
Target Age/Sex: 18 – 65 years of age Male and Female
Participants will receive at no cost: study product, study materials and study-specific procedures